Medicare Enrolled
Dr. John Kim, M.D.
Family Medicine · Cerritos, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. John Kim is a family medicine specialist in Cerritos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 2,584 Medicare services across 1,237 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $12,677 from 65 pharmaceutical and/or device companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$12,677 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,584
Medicare services
Top 7% in CA for family medicine
1,237
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~136 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
760 | $93 | $170 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
671 | $103 | $239 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
260 | $8 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
134 | $144 | $247 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
112 | $57 | $122 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
84 | $44 | $140 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
81 | $30 | $30 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
58 | $157 | $257 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
52 | $21 | $180 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
46 | $10 | $40 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
38 | $80 | $142 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $120 | $180 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $66 | $120 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
32 | $99 | $349 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 29 | $20 | $40 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
28 | $33 | $35 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
25 | $22 | $40 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
22 | $11 | $60 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
17 | $29 | $30 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
16 | $196 | $200 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
15 | $30 | $30 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
14 | $112 | $220 |
| New patient office visit, complex (60-74 min) | 13 | $162 | $250 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
12 | $29 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,677
Total received (2018-2024)
Avg $1,811/year across 7 years
Top 3% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
516
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,677 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,087
2023
$1,133
2022
$1,229
2021
$2,175
2020
$1,804
2019
$2,180
2018
$3,068
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$367
AstraZeneca Pharmaceuticals LP
$94
Exact Sciences Corporation
$61
Lilly USA, LLC
$56
AIMMUNE THERAPEUTICS, INC.
$56
Lundbeck LLC
$54
Otsuka America Pharmaceutical, Inc.
$35
Phathom Pharmaceuticals, Inc.
$31
Eisai Inc.
$31
Sumitomo Pharma America, Inc.
$30
ABBVIE INC.
$29
Amgen Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Biogen, Inc.
$24
Abbott Laboratories
$22
Boston Scientific Corporation
$22
Merck Sharp & Dohme LLC
$21
Radius Health, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Otsuka Pharmaceutical Development & Commercialization, Inc.
$20
VIVUS LLC
$20
Paratek Pharmaceuticals, Inc.
$18
Top 3 companies account for 48.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,701
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,266
AstraZeneca Pharmaceuticals LP
$1,265
Merck Sharp & Dohme Corporation
$938
Lilly USA, LLC
$683
Gilead Sciences, Inc.
$614
AbbVie Inc.
$519
PFIZER INC.
$482
Amgen Inc.
$419
Janssen Pharmaceuticals, Inc
$308
Novo Nordisk Inc
$286
AbbVie, Inc.
$275
Novartis Pharmaceuticals Corporation
$261
Ironwood Pharmaceuticals, Inc
$249
ABBVIE INC.
$217
Radius Health, Inc.
$204
Nestle HealthCare Nutrition Inc.
$195
Endogastric Solutions, Inc
$180
Allergan, Inc.
$164
Merck Sharp & Dohme LLC
$159
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$142
Horizon Therapeutics plc
$131
Allergan Inc.
$128
Exact Sciences Corporation
$126
Regeneron Healthcare Solutions, Inc.
$122
Abbott Laboratories
$108
Eisai Inc.
$106
Medtronic Vascular, Inc.
$103
Amarin Pharma Inc.
$100
Scilex Pharmaceuticals Inc.
$99
Lundbeck LLC
$92
Covidien LP
$76
Bayer HealthCare Pharmaceuticals Inc.
$68
NESTLE HEALTHCARE NUTRITION INC.
$56
Phathom Pharmaceuticals, Inc.
$56
AIMMUNE THERAPEUTICS, INC.
$56
Biohaven Pharmaceutical Holding Company Ltd.
$55
SANOFI-AVENTIS U.S. LLC
$53
VIVUS LLC
$48
MAYNE PHARMA COMMERCIAL LLC
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
Otsuka America Pharmaceutical, Inc.
$35
Kowa Pharmaceuticals America, Inc.
$33
Sumitomo Pharma America, Inc.
$30
GE HEALTHCARE
$25
Biogen, Inc.
$24
Alexion Pharmaceuticals, Inc.
$23
Corium, LLC
$23
DERMIRA, INC.
$22
Heron Therapeutics, Inc.
$22
Boston Scientific Corporation
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$20
Sun Pharmaceutical Industries Inc.
$20
Nuvectra Corporation
$19
Paratek Pharmaceuticals, Inc.
$18
Biohaven Pharmaceuticals, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$17
Teva Pharmaceuticals USA, Inc.
$17
Hikma Pharmaceuticals USA
$15
Eyevance Pharmaceuticals LLC
$15
Genentech USA, Inc.
$14
BIOTRONIK INC.
$13
Nevro Corp.
$13
IBSA Pharma Inc.
$13
Top 3 companies account for 33.4% of all-time payments
Associated products mentioned in payments ›
ADLARITY · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Algovita · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CREON · ClosureRFS · Cologuard Collection Kit · Creon · DRIZALMA SPRINKLE · DUZALLO · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · ESOPHYX · EVENITY · Epclusa · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GEMTESA · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Kyleena · LEQEMBI · LEQVIO · LINZESS · LIVALO · Leqembi · Licart · Livalo · MOUNJARO · Mitigare · NURTEC ODT · NUZYRA · Ozempic · PANCREAZE · PENNSAID · PNEUMOVAX 23 · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR 13 · PREVNAR 20 · Prolia · QBREXZA · QULIPTA · QUVIVIQ · RAYOS · RELISTOR ORAL · REXULTI · Repatha · SHINGRIX · SOLIQUA · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Senza Spinal Cord Stimulation System · Strensiq · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · UBRELVY · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Vemlidy · Victoza · XARELTO · XIFAXAN · Xofluza · ZENPEP · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zerviate · Zynrelef
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
3,939
Per 100K population
40.0
County median income
$87,760
Nearest hospital
COLLEGE HOSPITAL
0.6 mi
0.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 3% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kim performed 760 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $12,677 from 65 companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other family medicine physicians in Cerritos?
Dr. Kim's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Cerritos
Browse family medicine physicians in Cerritos ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology